Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
A Phase II, Open Label, Extension Study to Assess the Effect of PRO044 in Patients With Duchenne Muscular Dystrophy A Phase II, Open Label, Extension Study to Assess the Effect of PRO044 in Patients With Duchenne Mus ...
Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
A Phase I/IIa, Open Label, Escalating Dose, Pilot Study to Assess the Effect, Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous and Intravenous Doses of PRO044 in Patients With Duchenne Muscular Dystrophy A Phase I/IIa, Open Label, Escalating Dose, Pilot Study to Assess the Effect, Safety, Tolerability a ...